Orthocell (OCC) News Today → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free OCC Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOrthocell moves closer to US market clearance and salesproactiveinvestors.com - March 26 at 3:22 AMOrthocell Ltd OCCmorningstar.com - February 29 at 9:47 AMOrthocell raising $3.5 million; adds heavy hitters to registerproactiveinvestors.com - February 22 at 9:06 AMOrthocell (ASX:OCC) shareholders have earned a 23% CAGR over the last five yearsfinance.yahoo.com - January 15 at 12:51 AMOrthocell appoints former Deputy Prime Minister Kim Beazley as a directorau.investing.com - January 14 at 7:51 PMOrthocell tendon cell therapy as effective as surgery for chronic tennis elbowproactiveinvestors.com - November 13 at 11:25 PMOrthocell on the cusp of significant growthfinance.yahoo.com - November 1 at 7:15 PMOrthocell and University of Western Australia cement long-term partnership through equity exchangeproactiveinvestors.com.au - October 29 at 11:56 PMOrthocell and University of Western Australia cement long-term...proactiveinvestors.com - October 29 at 11:56 PMOrthocell Limited's (ASX:OCC) CEO Will Probably Find It Hard To See A Huge Raise This Yearfinance.yahoo.com - October 25 at 5:00 PMOrthocell has Striate+™ re-certified under stricter European medical device regulationsproactiveinvestors.com.au - August 23 at 11:22 PMBiotechs play the long game as always in a healthy June quarterau.investing.com - August 6 at 8:55 PMOrthocell thrilled to welcome John Van Der Wielen as chairmanproactiveinvestors.com.au - May 28 at 10:16 PMOrthocell appoints experienced executive John Van Der Wielen as independent non-executive chairmanproactiveinvestors.com - May 28 at 10:16 PMOCC.AX - Orthocell Limitedfinance.yahoo.com - May 25 at 7:07 PMOrthocell kicks off comparator study for nerve repair device Remplirproactiveinvestors.com.au - April 17 at 10:28 PMOrthocell welcomes globally recognised nerve surgeons to advisory boardfinance.yahoo.com - March 30 at 6:01 PMOrthocell appoints specialist US-based nerve surgeons to medical advisory boardproactiveinvestors.com - March 28 at 10:46 PMOrthocell welcomes high profile US-based healthcare specialist to the boardproactiveinvestors.com.au - March 7 at 11:28 PMOrthocell appoints US healthcare specialist as independent non-executive directorproactiveinvestors.com.au - March 7 at 11:28 PMOrthocell First Half 2023 Earnings: AU$0.021 loss per share (vs AU$0.024 loss in 1H 2022)finance.yahoo.com - March 3 at 4:25 PMThe Options Clearing Corporation: OCC Welcomes Jefferies Executive Joseph Lewis to Board of Directorsfinanznachrichten.de - February 26 at 11:25 AMOrthocell (ASX:OCC) shareholders have earned a 4.7% CAGR over the last five yearsfinance.yahoo.com - February 8 at 6:30 PMOrthocell’s Remplir™ added to Australian Prostheses listproactiveinvestors.com.au - November 1 at 11:44 PMASX Biotech Stocks: Surgeons can now be reimbursed for using Orthocell’s nerve repair devicemsn.com - November 1 at 8:41 AMOrthocell secures inclusion for Remplir™ on the prostheses listproactiveinvestors.com.au - November 1 at 8:41 AMOrthocell data demonstrates OrthoATI rotator cuff treatment more effective than steroid injectionsproactiveinvestors.com.au - September 28 at 8:41 PMOrthocell secures first purchase orders for Striate+ and Remplir under new distribution dealsproactiveinvestors.com.au - September 27 at 12:10 AMOrthocell talks appointment of exclusive Australian distributor for Remplir™proactiveinvestors.com.au - September 7 at 3:52 AMOrthocell appoints exclusive Australian distributor for Remplir™ nerve repair deviceproactiveinvestors.com.au - September 6 at 10:51 PMInvesting in Orthocell (ASX:OCC) five years ago would have delivered you a 18% gainfinance.yahoo.com - September 1 at 6:33 PMOCC.AX - Orthocell Ltd | Stock Price & Latest News | Reutersreuters.com - August 5 at 11:55 PMOrthocell signs defining licence and distribution agreementproactiveinvestors.com.au - July 21 at 10:28 PMOrthocell soars on securing exclusive A$23.1 million global licence and manufacturing agreement with BioHorizonsproactiveinvestors.com.au - June 28 at 4:20 AMOrthocell secures exclusive A$23.1 million global licence and manufacturing agreement with BioHorizonsproactiveinvestors.com.au - June 27 at 11:19 PMWe're Hopeful That Orthocell (ASX:OCC) Will Use Its Cash Wiselyfinance.yahoo.com - June 22 at 8:48 PMOrthocell delivers outstanding results in Remplir™ nerve regeneration trialproactiveinvestors.com.au - June 7 at 3:47 AMOrthocell welcomes final "life-altering" data for nerve reconstruction studyproactiveinvestors.com.au - June 7 at 3:47 AMOrthocell receives $2.2 million R&D grant for scale up and developmentproactiveinvestors.com.au - June 2 at 8:54 PMOrthocell receives TGA approval for first Australian-made collagen nerve repair membrane, Remplir™proactiveinvestors.com - March 22 at 1:43 AMProactive news headlines including Surefire Resources, Elementos, Pharmaxis and Orthocell Ltduk.finance.yahoo.com - March 21 at 3:01 AMOrthocell surges on receiving Australian regulatory approval for Remplir™ nerve repair deviceproactiveinvestors.com.au - March 20 at 10:00 PMOrthocell sees “exciting year ahead” as it hits US key opinion leader sales growth milestone of 1,500 Striate+™proactiveinvestors.com.au - February 28 at 12:22 AMOrthocell delivers busy half-year, advancing development and commercialisation of key pipeline productsproactiveinvestors.com.au - February 24 at 9:47 AMOrthocell’s December quarter highlights the progress it is making in regenerating mobilityproactiveinvestors.com.au - February 1 at 2:45 AMOrthocell’s SmrtGraft™ tendon repair treatment flexes its muscles in new shoulder studyproactiveinvestors.com.au - December 16 at 12:58 AMOrthocell releases clinical data confirming OrthoATI™ efficacy in treating chronic shoulder tendon injuries, shares upproactiveinvestors.com - December 8 at 12:39 AMOrthocell (ASX:OCC) share price surges 13% on study successmsn.com - December 8 at 12:39 AMOrthocell finds further success in clinical tendon studyproactiveinvestors.com.au - December 7 at 7:38 PMWe're Not Worried About Orthocell's (ASX:OCC) Cash Burnfinance.yahoo.com - December 7 at 12:19 AM Get Orthocell News Delivered to You Automatically Sign up to receive the latest news and ratings for OCC and its competitors with MarketBeat's FREE daily newsletter. Email Address top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… OCC Media Mentions By Week OCC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCC News Sentiment▼1.000.44▲Average Medical News Sentiment OCC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCC Articles This Week▼10▲OCC Articles Average Week Get Orthocell News Delivered to You Automatically Sign up to receive the latest news and ratings for OCC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Arno Therapeutics News Today Artelo Biosciences News Today Ascletis Pharma News Today Awakn Life Sciences News Today AXIM Biotechnologies News Today BerGenBio ASA News Today BriaCell Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:OCC) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthocell Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
